RecruitingNCT06412172

The Natural History and Biological Study of Pulmonary Recurrent Respiratory Papillomatosis (pRRP)


Sponsor

Massachusetts General Hospital

Enrollment

100 participants

Start Date

Apr 15, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

Recurrent respiratory papillomatosis (RRP) is an orphan disease that affects approximately 20,000 people in the United States and is caused by infection with human papillomavirus (HPV) types 6 and 11. Since RRP is an orphan disease, it is an understudied disease entity with correspondingly few treatment options. The investigators hypothesize that by understanding the biology of RRP and the failed host immune responses against HPV, novel and rational therapies can be developed. This study will examine the genetic and immunologic alterations found in these rare tumors and distant metastatic involved sites (such as the lung) in patients diagnosed with RRP.


Eligibility

Min Age: 18 YearsMax Age: 99 Years

Inclusion Criteria2

  • History of HPV-associated Recurrent Respiratory Papillomatosis
  • Has pulmonary lesions

Exclusion Criteria1

  • None

Locations(1)

Yale School of Medicine

New Haven, Connecticut, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06412172


Related Trials